Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-18

Clinical Trial Update: Oral Rehydration Therapy in Burn Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oral rehydration therapy in burn patients across various percent body surface area. The trial was terminated, and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Rehydration Therapy

Snippet

Sponsor: Johns Hopkins University | Conditions: Burn Any Degree Involving 20-29 Percent of Body Surface, Burn Any Degree Involving 30-39 Percent of Body Surface | Phase 1 | Status: TERMINATED | Results posted: 2019-02-18